Zenas BioPharma (ZBIO) Operating Margin (2023 - 2025)
Zenas BioPharma (ZBIO) recorded quarterly Operating Margin of 373.3% in Q1 2025, up 66.44% quarter-over-quarter from 1112.46% in Q4 2024.
Zenas BioPharma (ZBIO) Operating Margin (2023 - 2025) Analysis & Trends
Zenas BioPharma's Operating Margin history runs 3 years deep, the most recent figure standing at 373.3% for Q1 2025.
- In Q1 2025, Operating Margin changed N/A year-over-year to 373.3%; the TTM figure through Dec 2025 stood at 3830.57% (down 55283.0% YoY), while the FY2025 annual figure was 3830.57%, down 55281.0% from the prior year.
- Operating Margin was 373.3% for Q1 2025 at Zenas BioPharma, up from 1112.46% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 71.25% in Q3 2023 to a low of 1112.46% in Q4 2024.
- Historically, Operating Margin has averaged 471.5% across 3 years, with a median of 373.3% in 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zenas BioPharma | 1.10 Bn | 379.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -373.30% |
| Dec 31, 2024 | -1,112.46% |
| Sep 30, 2023 | 71.25% |